MONDELEZ INTERNATIONAL INC-A (MDLZ) Stock Fundamental Analysis

NASDAQ:MDLZ • US6092071058

59.17 USD
-1.27 (-2.1%)
Last: Mar 3, 2026, 03:07 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to MDLZ. MDLZ was compared to 88 industry peers in the Food Products industry. MDLZ has a medium profitability rating, but doesn't score so well on its financial health evaluation. MDLZ is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year MDLZ was profitable.
  • MDLZ had a positive operating cash flow in the past year.
  • Each year in the past 5 years MDLZ has been profitable.
  • In the past 5 years MDLZ always reported a positive cash flow from operatings.
MDLZ Yearly Net Income VS EBIT VS OCF VS FCFMDLZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

  • MDLZ's Return On Assets of 3.43% is fine compared to the rest of the industry. MDLZ outperforms 64.77% of its industry peers.
  • The Return On Equity of MDLZ (9.49%) is better than 73.86% of its industry peers.
  • MDLZ's Return On Invested Capital of 5.26% is fine compared to the rest of the industry. MDLZ outperforms 62.50% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for MDLZ is significantly below the industry average of 28.23%.
Industry RankSector Rank
ROA 3.43%
ROE 9.49%
ROIC 5.26%
ROA(3y)5.7%
ROA(5y)5.47%
ROE(3y)14.7%
ROE(5y)13.89%
ROIC(3y)7.9%
ROIC(5y)7.13%
MDLZ Yearly ROA, ROE, ROICMDLZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • MDLZ's Profit Margin of 6.36% is amongst the best of the industry. MDLZ outperforms 81.82% of its industry peers.
  • In the last couple of years the Profit Margin of MDLZ has declined.
  • With a decent Operating Margin value of 9.48%, MDLZ is doing good in the industry, outperforming 75.00% of the companies in the same industry.
  • MDLZ's Operating Margin has declined in the last couple of years.
  • MDLZ's Gross Margin of 28.38% is fine compared to the rest of the industry. MDLZ outperforms 67.05% of its industry peers.
  • MDLZ's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.48%
PM (TTM) 6.36%
GM 28.38%
OM growth 3Y-8.01%
OM growth 5Y-9.55%
PM growth 3Y-9.66%
PM growth 5Y-13.81%
GM growth 3Y-7.55%
GM growth 5Y-6.31%
MDLZ Yearly Profit, Operating, Gross MarginsMDLZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MDLZ is still creating some value.
  • The number of shares outstanding for MDLZ has been reduced compared to 1 year ago.
  • MDLZ has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for MDLZ is higher compared to a year ago.
MDLZ Yearly Shares OutstandingMDLZ Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
MDLZ Yearly Total Debt VS Total AssetsMDLZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 2.29 indicates that MDLZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • MDLZ has a Altman-Z score of 2.29. This is comparable to the rest of the industry: MDLZ outperforms 57.95% of its industry peers.
  • The Debt to FCF ratio of MDLZ is 6.55, which is on the high side as it means it would take MDLZ, 6.55 years of fcf income to pay off all of its debts.
  • MDLZ has a better Debt to FCF ratio (6.55) than 68.18% of its industry peers.
  • A Debt/Equity ratio of 0.77 indicates that MDLZ is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.77, MDLZ is not doing good in the industry: 60.23% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 6.55
Altman-Z 2.29
ROIC/WACC0.72
WACC7.32%
MDLZ Yearly LT Debt VS Equity VS FCFMDLZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.3 Liquidity

  • MDLZ has a Current Ratio of 0.59. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of MDLZ (0.59) is worse than 85.23% of its industry peers.
  • A Quick Ratio of 0.39 indicates that MDLZ may have some problems paying its short term obligations.
  • MDLZ has a worse Quick ratio (0.39) than 79.55% of its industry peers.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.39
MDLZ Yearly Current Assets VS Current LiabilitesMDLZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

4

3. Growth

3.1 Past

  • The earnings per share for MDLZ have decreased strongly by -15.36% in the last year.
  • The Earnings Per Share has been growing slightly by 2.19% on average over the past years.
  • Looking at the last year, MDLZ shows a small growth in Revenue. The Revenue has grown by 5.75% in the last year.
  • Measured over the past years, MDLZ shows a small growth in Revenue. The Revenue has been growing by 7.71% on average per year.
EPS 1Y (TTM)-15.36%
EPS 3Y-0.68%
EPS 5Y2.19%
EPS Q2Q%10.77%
Revenue 1Y (TTM)5.75%
Revenue growth 3Y6.96%
Revenue growth 5Y7.71%
Sales Q2Q%9.29%

3.2 Future

  • MDLZ is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.76% yearly.
  • The Revenue is expected to grow by 3.25% on average over the next years.
EPS Next Y9.49%
EPS Next 2Y9.35%
EPS Next 3Y9.06%
EPS Next 5Y8.76%
Revenue Next Year3.71%
Revenue Next 2Y3.46%
Revenue Next 3Y3.38%
Revenue Next 5Y3.25%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MDLZ Yearly Revenue VS EstimatesMDLZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
MDLZ Yearly EPS VS EstimatesMDLZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 20.26, the valuation of MDLZ can be described as rather expensive.
  • MDLZ's Price/Earnings is on the same level as the industry average.
  • MDLZ's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.13.
  • With a Price/Forward Earnings ratio of 18.51, MDLZ is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of MDLZ indicates a somewhat cheap valuation: MDLZ is cheaper than 64.77% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.11. MDLZ is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 20.26
Fwd PE 18.51
MDLZ Price Earnings VS Forward Price EarningsMDLZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as MDLZ.
  • MDLZ's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MDLZ is cheaper than 62.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 23.45
EV/EBITDA 18.73
MDLZ Per share dataMDLZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MDLZ does not grow enough to justify the current Price/Earnings ratio.
  • MDLZ has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.13
PEG (5Y)9.24
EPS Next 2Y9.35%
EPS Next 3Y9.06%

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.34%, MDLZ has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 2.22, MDLZ pays a bit more dividend than its industry peers.
  • MDLZ's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.34%

5.2 History

  • The dividend of MDLZ is nicely growing with an annual growth rate of 10.23%!
  • MDLZ has been paying a dividend for at least 10 years, so it has a reliable track record.
  • MDLZ has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)10.23%
Div Incr Years11
Div Non Decr Years11
MDLZ Yearly Dividends per shareMDLZ Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • MDLZ pays out 101.47% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of MDLZ is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP101.47%
EPS Next 2Y9.35%
EPS Next 3Y9.06%
MDLZ Yearly Income VS Free CF VS DividendMDLZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B
MDLZ Dividend Payout.MDLZ Dividend Payout, showing the Payout Ratio.MDLZ Dividend Payout.PayoutRetained Earnings

MONDELEZ INTERNATIONAL INC-A

NASDAQ:MDLZ (3/3/2026, 3:07:06 PM)

59.17

-1.27 (-2.1%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-03
Earnings (Next)04-27
Inst Owners89.35%
Inst Owner Change-0.68%
Ins Owners0.15%
Ins Owner Change5.05%
Market Cap75.85B
Revenue(TTM)38.54B
Net Income(TTM)2.45B
Analysts78.24
Price Target67.99 (14.91%)
Short Float %2.44%
Short Ratio2.74
Dividend
Industry RankSector Rank
Dividend Yield 3.34%
Yearly Dividend1.91
Dividend Growth(5Y)10.23%
DP101.47%
Div Incr Years11
Div Non Decr Years11
Ex-Date03-31
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.76%
Min EPS beat(2)0.24%
Max EPS beat(2)1.28%
EPS beat(4)4
Avg EPS beat(4)4.31%
Min EPS beat(4)0.24%
Max EPS beat(4)10.18%
EPS beat(8)7
Avg EPS beat(8)5.06%
EPS beat(12)11
Avg EPS beat(12)5.53%
EPS beat(16)15
Avg EPS beat(16)5.46%
Revenue beat(2)0
Avg Revenue beat(2)-0.89%
Min Revenue beat(2)-1.64%
Max Revenue beat(2)-0.15%
Revenue beat(4)0
Avg Revenue beat(4)-1.07%
Min Revenue beat(4)-2.09%
Max Revenue beat(4)-0.15%
Revenue beat(8)0
Avg Revenue beat(8)-1.43%
Revenue beat(12)3
Avg Revenue beat(12)-0.47%
Revenue beat(16)7
Avg Revenue beat(16)0.45%
PT rev (1m)-1.22%
PT rev (3m)-3.03%
EPS NQ rev (1m)-22.7%
EPS NQ rev (3m)-24.25%
EPS NY rev (1m)-0.24%
EPS NY rev (3m)-2.18%
Revenue NQ rev (1m)-1.81%
Revenue NQ rev (3m)-2.01%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.57%
Valuation
Industry RankSector Rank
PE 20.26
Fwd PE 18.51
P/S 1.97
P/FCF 23.45
P/OCF 16.8
P/B 2.94
P/tB N/A
EV/EBITDA 18.73
EPS(TTM)2.92
EY4.93%
EPS(NY)3.2
Fwd EY5.4%
FCF(TTM)2.52
FCFY4.27%
OCF(TTM)3.52
OCFY5.95%
SpS30.06
BVpS20.16
TBVpS-14.14
PEG (NY)2.13
PEG (5Y)9.24
Graham Number36.39
Profitability
Industry RankSector Rank
ROA 3.43%
ROE 9.49%
ROCE 7.36%
ROIC 5.26%
ROICexc 5.48%
ROICexgc 44.22%
OM 9.48%
PM (TTM) 6.36%
GM 28.38%
FCFM 8.39%
ROA(3y)5.7%
ROA(5y)5.47%
ROE(3y)14.7%
ROE(5y)13.89%
ROIC(3y)7.9%
ROIC(5y)7.13%
ROICexc(3y)8.16%
ROICexc(5y)7.43%
ROICexgc(3y)63.45%
ROICexgc(5y)50.76%
ROCE(3y)10.65%
ROCE(5y)9.63%
ROICexgc growth 3Y21.26%
ROICexgc growth 5Y4.14%
ROICexc growth 3Y1.32%
ROICexc growth 5Y-3.02%
OM growth 3Y-8.01%
OM growth 5Y-9.55%
PM growth 3Y-9.66%
PM growth 5Y-13.81%
GM growth 3Y-7.55%
GM growth 5Y-6.31%
F-Score5
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 6.55
Debt/EBITDA 3.97
Cap/Depr 94.18%
Cap/Sales 3.32%
Interest Coverage 6.41
Cash Conversion 90.06%
Profit Quality 131.99%
Current Ratio 0.59
Quick Ratio 0.39
Altman-Z 2.29
F-Score5
WACC7.32%
ROIC/WACC0.72
Cap/Depr(3y)97.41%
Cap/Depr(5y)92.16%
Cap/Sales(3y)3.4%
Cap/Sales(5y)3.29%
Profit Quality(3y)93.68%
Profit Quality(5y)93.08%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.36%
EPS 3Y-0.68%
EPS 5Y2.19%
EPS Q2Q%10.77%
EPS Next Y9.49%
EPS Next 2Y9.35%
EPS Next 3Y9.06%
EPS Next 5Y8.76%
Revenue 1Y (TTM)5.75%
Revenue growth 3Y6.96%
Revenue growth 5Y7.71%
Sales Q2Q%9.29%
Revenue Next Year3.71%
Revenue Next 2Y3.46%
Revenue Next 3Y3.38%
Revenue Next 5Y3.25%
EBIT growth 1Y-45.43%
EBIT growth 3Y-1.61%
EBIT growth 5Y-2.57%
EBIT Next Year34.04%
EBIT Next 3Y15.06%
EBIT Next 5Y13.29%
FCF growth 1Y-8.17%
FCF growth 3Y2.52%
FCF growth 5Y0.85%
OCF growth 1Y-8.07%
OCF growth 3Y4.92%
OCF growth 5Y2.63%

MONDELEZ INTERNATIONAL INC-A / MDLZ FAQ

Can you provide the ChartMill fundamental rating for MONDELEZ INTERNATIONAL INC-A?

ChartMill assigns a fundamental rating of 4 / 10 to MDLZ.


Can you provide the valuation status for MONDELEZ INTERNATIONAL INC-A?

ChartMill assigns a valuation rating of 4 / 10 to MONDELEZ INTERNATIONAL INC-A (MDLZ). This can be considered as Fairly Valued.


What is the profitability of MDLZ stock?

MONDELEZ INTERNATIONAL INC-A (MDLZ) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for MDLZ stock?

The Price/Earnings (PE) ratio for MONDELEZ INTERNATIONAL INC-A (MDLZ) is 20.26 and the Price/Book (PB) ratio is 2.94.


Can you provide the dividend sustainability for MDLZ stock?

The dividend rating of MONDELEZ INTERNATIONAL INC-A (MDLZ) is 6 / 10 and the dividend payout ratio is 101.47%.